{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:35:45Z","timestamp":1761507345785,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jamda.2022.10.009","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T20:02:51Z","timestamp":1668715371000},"page":"213-219.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recent Hospitalization and Initiation of Antiepileptics Among Persons With Alzheimer\u2019s Disease"],"prefix":"10.1016","volume":"24","author":[{"given":"Jenna","family":"Elo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Maija","family":"Tolppanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjaana","family":"Koponen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miia","family":"Tiihonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4714-455X","authenticated-orcid":false,"given":"Sirpa","family":"Hartikainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 7","key":"10.1016\/j.jamda.2022.10.009_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1528-1167.2012.03712.x","article-title":"Why are antiepileptic drugs used for nonepileptic conditions?","volume":"53","author":"Bialer","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.jamda.2022.10.009_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1684\/j.1950-6945.2004.tb00053.x","article-title":"Antiepileptic drugs: indications other than epilepsy","volume":"6","author":"Spina","year":"2004","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.jamda.2022.10.009_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1592\/phco.22.5.329.33192","article-title":"Strategies for optimizing antiepileptic drug therapy in elderly people","volume":"22","author":"Lackner","year":"2002","journal-title":"Pharmacotherapy"},{"issue":"Suppl 1","key":"10.1016\/j.jamda.2022.10.009_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.yebeh.2003.11.008","article-title":"Cognitive side effects of antiepileptic drugs","volume":"5","author":"Ortinski","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jamda.2022.10.009_bib5","doi-asserted-by":"crossref","first-page":"e009742","DOI":"10.1161\/JAHA.118.009742","article-title":"Antiepileptic drug use and the risk of stroke among community-dwelling people with Alzheimer disease: a Matched Cohort Study","volume":"7","author":"Sarycheva","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jamda.2022.10.009_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/1715163517690744","article-title":"Risk of falls associated with antiepileptic drug use in ambulatory elderly populations: a systematic review","volume":"150","author":"Maximos","year":"2017","journal-title":"Can Pharm J (Ott)"},{"key":"10.1016\/j.jamda.2022.10.009_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-180912","article-title":"Antiepileptic drug use is associated with an increased risk of pneumonia among community-dwelling persons with Alzheimer's disease-Matched Cohort Study","volume":"68","author":"Taipale","year":"2019","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2022.10.009_bib8","first-page":"e2099","article-title":"Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease","volume":"94","author":"Sarycheva","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2022.10.009_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1684\/epd.2014.0714","article-title":"Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs","volume":"16","author":"Zaccara","year":"2014","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.jamda.2022.10.009_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1517\/17425255.2012.645535","article-title":"Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects","volume":"8","author":"Jankovic","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jamda.2022.10.009_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JAD-2011-110200","article-title":"Use of antiepileptic drugs among community-dwelling persons with Alzheimer's disease in Finland","volume":"26","author":"Bell","year":"2011","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2022.10.009_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3233\/JAD-180594","article-title":"Incidence and prevalence of antiepileptic medication use in community-dwelling persons with and without Alzheimer's disease","volume":"66","author":"Sarycheva","year":"2018","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2022.10.009_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/JAD-170031","article-title":"Relative incidence of seizures and myoclonus in Alzheimer's disease, dementia with lewy bodies, and frontotemporal dementia","volume":"60","author":"Beagle","year":"2017","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2022.10.009_bib14","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/archneurol.2009.130","article-title":"Seizures in Alzheimer disease: who, when, and how common?","volume":"66","author":"Scarmeas","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jamda.2022.10.009_bib15","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1528-1167.2006.00554.x","article-title":"Incidence and predictors of seizuresn patients with Alzheimer's disease","volume":"47","author":"Amatniek","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.jamda.2022.10.009_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.eplepsyres.2015.05.009","article-title":"Incidence and risk of seizures in Alzheimer's disease: A nationwide population-based cohort study","volume":"115","author":"Cheng","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jamda.2022.10.009_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/ene.14043","article-title":"Increased risk of epilepsy in patients registered in the Swedish Dementia Registry","volume":"27","author":"Zelano","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jamda.2022.10.009_bib18","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jamda.2019.05.022","article-title":"When less is more, but still not enough: why focusing on limiting antipsychotics in people with dementia is the wrong policy imperative","volume":"20","author":"Kales","year":"2019","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2022.10.009_bib19","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jamda.2020.05.039","article-title":"Trends in antipsychotic and mood stabilizer prescribing in long-term care in the U.S.: 2011-2014","volume":"21","author":"Gerlach","year":"2020","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2022.10.009_bib20","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1176\/appi.ajp.21060591","article-title":"Evaluation of antipsychotic reduction efforts in patients with dementia in Veterans Health Administration Nursing Homes","volume":"179","author":"Gerlach","year":"2022","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2022.10.009_bib21","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jamda.2020.12.021","article-title":"Does recent hospitalization increase antipsychotic initiation among community dwellers with Alzheimer's disease?","volume":"22","author":"Hakala","year":"2021","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2022.10.009_bib22","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/gps.5505","article-title":"Association of recent hospitalisation with antidepressant initiation among community dwellers with Alzheimer's disease","volume":"36","author":"Tarvainen","year":"2021","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2022.10.009_bib23","doi-asserted-by":"crossref","first-page":"e012100","DOI":"10.1136\/bmjopen-2016-012100","article-title":"Cohort profile: the finnish medication and Alzheimer's disease (MEDALZ) study","volume":"6","author":"Tolppanen","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jamda.2022.10.009_bib24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"year":"1994","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV","key":"10.1016\/j.jamda.2022.10.009_bib25"},{"key":"10.1016\/j.jamda.2022.10.009_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.kjms.2011.10.025","article-title":"Mood stabilizers for the treatment of behavioral and psychological symptoms of dementia: an update review","volume":"28","author":"Yeh","year":"2012","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.jamda.2022.10.009_bib29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/YCO.0b013e32835f414b","article-title":"Agitation and aggression in people with Alzheimer's disease","volume":"26","author":"Ballard","year":"2013","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.jamda.2022.10.009_bib30","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4088\/JCP.12m07918","article-title":"Efficacy of nonpharmacologic interventions for agitation in advanced dementia: a randomized, placebo-controlled trial","volume":"73","author":"Cohen-Mansfield","year":"2012","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jamda.2022.10.009_bib31","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/jama.288.12.1475","article-title":"Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study","volume":"288","author":"Lyketsos","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2022.10.009_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1192\/bjp.bp.113.130948","article-title":"Behavioural and psychiatric symptoms in people with dementia admitted to the acute hospital: prospective cohort study","volume":"205","author":"Sampson","year":"2014","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jamda.2022.10.009_bib33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/ijcp.12182","article-title":"Pregabalin is increasingly prescribed for neuropathic pain, generalised anxiety disorder and epilepsy but many patients discontinue treatment","volume":"68","author":"Wettermark","year":"2014","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jamda.2022.10.009_bib34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clinthera.2007.01.013","article-title":"Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders","volume":"29","author":"Tassone","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.jamda.2022.10.009_bib35","first-page":"227","article-title":"Treating painful diabetic peripheral neuropathy: an update","volume":"94","author":"Snyder","year":"2016","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jamda.2022.10.009_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1468-1331.2004.00992.x","article-title":"The epidemiology of epilepsy in Europe \u2013 a systematic review","volume":"12","author":"Forsgren","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jamda.2022.10.009_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.seizure.2015.06.016","article-title":"Choice of the first anti-epileptic drug in elderly patients with newly diagnosed epilepsy: a Finnish retrospective study","volume":"31","author":"Bruun","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.jamda.2022.10.009_bib39","first-page":"CD003945","article-title":"Valproate preparations for agitation in dementia","volume":"10","author":"Baillon","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2022.10.009_bib40","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archgenpsychiatry.2011.72","article-title":"Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease","volume":"68","author":"Tariot","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jamda.2022.10.009_bib41","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.euroneuro.2014.10.004","article-title":"High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort","volume":"24","author":"Taipale","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jamda.2022.10.009_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2016.02.013","article-title":"Challenges in the pharmacological management of epilepsy and its causes in the elderly","volume":"106","author":"Ferlazzo","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jamda.2022.10.009_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.ackd.2015.08.004","article-title":"Structural and functional changes with the aging kidney","volume":"23","author":"Denic","year":"2016","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.jamda.2022.10.009_bib44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1176\/appi.neuropsych.15060143","article-title":"Clinical and neurophysiologic characteristics of unprovoked seizures in patients diagnosed with dementia","volume":"28","author":"Sarkis","year":"2016","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.jamda.2022.10.009_bib45","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/1403494812456637","article-title":"Quality of the Finnish Hospital Discharge Register: a systematic review","volume":"40","author":"Sund","year":"2012","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.jamda.2022.10.009_bib46","first-page":"303","volume":"10","author":"Solomon","year":"2014"},{"key":"10.1016\/j.jamda.2022.10.009_bib47","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/11315960-000000000-00000","article-title":"Validity of the Finnish Prescription Register for measuring psychotropic drug exposures among elderly finns: a population-based intervention study","volume":"27","author":"Rikala","year":"2010","journal-title":"Drugs Aging"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861022007915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861022007915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:29:50Z","timestamp":1761506990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861022007915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1525861022007915"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2022.10.009","relation":{},"ISSN":["1525-8610"],"issn-type":[{"type":"print","value":"1525-8610"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent Hospitalization and Initiation of Antiepileptics Among Persons With Alzheimer\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2022.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}